How to Judge a Cosmetics OEM Factory's R&D Strength: 5 Signs
Published 2026-08-22 00:00:00 · Tiensi
Guide // R&D INSIGHT
Choosing a should not hinge only on plant size, equipment count or promotional material. What truly decides product competitiveness is the factory's R&D team, scientific system, patent and formula reserve, lab-testing capability, industry-academia resources and ingredient R&D ability behind it. From five core metrics, this article helps brand owners quickly judge a 's R&D strength.
01
R&D team and scientific systemThe most direct manifestation of R&D strength is people. A contract manufacturer's R&D team size, educational composition and whether it is led by PhDs/experts is the baseline for judging its R&D capability.
What to look at?
① Team education and professional background
Whether it is led by a PhD or well-known industry scientist; whether team members' backgrounds span chemistry, pharmacy, biology and skin science; whether experts with medical backgrounds join formula development, forming a medical-research co-creation model.
② Completeness of the scientific system
Don't just count R&D staff — look at whether the R&D system is complete. Mature contract manufacturers usually have a systematic research layout: an independent R&D center or institute, subdivided departments such as an efficacy-evaluation center and process-technology center, and high-end talent platforms like a postdoctoral research workstation.
③ R&D investment ratio
The share of R&D investment in sales is a key indicator of whether a company truly values R&D. Leading contract manufacturers typically invest 5%-10% of annual sales into R&D year after year.
Take as an example
DEVA International">DEVA International has gathered a team of 30-plus industry experts led by Dr. Pang Keliang, Dr. Qiu Xiaoyi, Dr. Yang Botao, Professor Qu Haihong and Dr. Zhu Baofu, building the "Two Academies, Two Stations, Three Centers" R&D system — two research institutes (the Natural Guozhuang Research Institute and the Shennongjia Natural Beauty Ingredient Research Institute), two workstations (the cosmetics postdoctoral research workstation and the Guangdong Province science and technology commissioner workstation), and three centers (the beauty application R&D center, the process-technology research center and the cosmetics evaluation center). It invests over 8% of annual sales in R&D — a high level among cosmetics supply-chain enterprises.
02
Patent count and formula reservePatents and the formula library are the direct embodiment of a contract manufacturer's R&D output and the source of brand product differentiation.
What to look at?
Number of national patents: focus on invention-patent count and whether patents cover formula, ingredient and process dimensions.
Mature formula reserve: understand the library size, category coverage and formula reserves across efficacy directions.
Special-use cosmetics permit count: brightening, sunscreen and spot-fading are special-use cosmetics requiring registration; the related technical accumulation can indicate efficacy-skincare R&D capability.
Take DEVA International as an example
DEVA International has accumulated 70-plus national patents spanning brightening-spot-fading, sunscreen-active combinations and more; holds 5,000-plus mature, high-efficiency plant-skincare core formulas covering infant skincare to efficacy skincare in full; holds 22 cosmetics special permits with 21 under application, and as a core member helped draft 7 group standards including children's cleansing mousse. Over the past three years its annual new-product filings have ranked among the top three in Guangzhou's Huangpu District.
03
Laboratory equipment and testing capabilityR&D cannot rest on paper alone; a lab's equipment level and testing capability directly set the floor for product quality.
What to look at?
① Lab classification and configuration
Mature contract manufacturers typically equip multiple specialized labs with clear roles — efficacy-evaluation rooms, active-ingredient analysis rooms, heavy-metal testing rooms, plant-extraction-and-fermentation rooms, container-testing rooms and so on.
② Testing system and standards
Focus on whether a complete cosmetics safety-assessment system is built, whether testing covers stability, safety, efficacy and microbiology, and whether it has 150-plus efficacy and safety test standards.
Take DEVA International as an example
DEVA International's core labs were designed and built to CNAS standards, equipped with cell labs, product-efficacy evaluation rooms, plant-extraction-and-fermentation rooms, active-ingredient analysis rooms, heavy-metal testing rooms, chick chorioallantoic membrane (HET-CAM) labs and more. It is equipped with internationally high-end testing and analysis devices such as the U.S. lab-grade VISIA facial skin imaging analyzer, Japan-imported high-performance liquid and gas chromatographs, atomic fluorescence photometer and one-hundred-thousandth electronic balance, forming 150-plus efficacy and safety test standards — including cell-evaluation, chorioallantoic-membrane irritation and preservation-challenge tests — and a complete safety-assessment system compliant with national standards.
04
Industry-academia-research cooperation and external scientific resourcesA contract manufacturer's R&D strength depends not only on its internal team but also on its ability to integrate external scientific resources. Deep cooperation with universities, research institutes and hospitals signals a company's underlying capacity for sustained innovation.
What to look at?
Cooperation with universities: whether it has built industry-academia-research practice bases with renowned institutions and owns joint labs or joint research centers.
Cooperation with research institutes: whether it joins national-level research-institute projects and owns high-end talent platforms such as a postdoctoral research workstation.
Medical-research co-creation model: whether medical PhDs or clinical experts join product development and whether it runs clinical-validation projects with hospitals or dermatology departments.
Take DEVA International as an example
DEVA International built industry-academia-research practice bases with six universities including Guangdong Pharmaceutical University, and owns the DEVA & France Sicor Group joint innovation laboratory and the DEVA & Hi! Papa infant-product technology research center. In 2025 it joined the National Engineering Research Center for Novel Drugs to build a joint innovation laboratory for efficacy skincare. It was also awarded the Guangzhou Bay Area Biomedical Research Institute — cosmetics postdoctoral research workstation and doctoral science-and-technology commissioner workstation, focusing on new ingredients, formulas and technologies. In medical-research co-creation, DEVA invited Dr. Yang Botao, a medical PhD and deputy chief physician of dermatology and aesthetics at the Affiliated Hospital of Guangzhou Medical University, to provide deep clinical-medicine perspective for product development.
05
Ingredient R&D and supply-chain controlIngredients are the source of cosmetics quality. Whether a contract manufacturer has ingredient R&D capability and controls core-ingredient resources is a key indicator of R&D depth. Especially as "China ingredients" rise, contract manufacturers with independent ingredient R&D can give brands stronger differentiation.
What to look at?
① Ingredient R&D capability
Whether it has an independent ingredient R&D team or institute; whether it masters core technologies like rare-plant extraction and fermentation; whether its self-developed ingredients have passed national new-ingredient filing.
② Control over the ingredient supply chain
Whether it has strategic cooperation with global branded ingredient suppliers; whether it owns cultivation bases or ingredient-origin partnerships; whether it can provide brands with ingredient-IP customization, traceability and technical services.
Take DEVA International as an example
DEVA International reached a strategic cooperation with the Hubei Shennongjia Forest District government, building a 2,000-mu herbal cultivation base and establishing Natural (Guangzhou) New Material Research and Development Co., Ltd., gathering a scientific team led by Dr. Zhu Baofu, Dr. Zhao Haishan, Dr. Mo Kaiju and Dr. Ding Jinlong. Major breakthroughs have been achieved in applying Shennongjia's distinctive rare plants: seven mass-producible, high-efficacy rare-species extracts and compound ingredients — including Shennong fragrant chrysanthemum, Shennong immortal algae, Shennong hundred-flower honey ferment, and Shennong black-tea ferment — have been successfully developed, with Shennong fragrant chrysanthemum already passing national new-ingredient filing. At the same time, all DEVA ingredients come from globally renowned suppliers in the U.S., Spain, France, Germany, Japan, South Korea and beyond, with strategic alliances established with AkzoNobel, Clariant, BASF, Symrise, Dow, DSM, DuPont and other global leaders.
06
Quick-reference table for evaluating a contract manufacturer's R&D strengthEvaluation dimension |
Basic level |
Excellent level |
DEVA International level |
|---|---|---|---|
| R&D team | 5-10 engineers | PhD-led, 30+ team | 4 PhDs/scientists leading, 30+ industry experts |
| Scientific system | Single R&D department | Has institute/research center | Two Academies, Two Stations, Three Centers; postdoctoral workstation |
| R&D investment | 3%-5% | 5%-8% | 8%+ |
| Patent count | Within 10 | 30-50 | 70+ national patents |
| Formula reserve | 500-1000 | 2000-3000 | 5000+ mature formulas |
| Special permits | 0-5 | 10-15 | 22 permits, 21 under application |
| Laboratory | Basic physicochemical testing | Multiple specialized labs | CNAS-standard lab, 150+ test standards |
| Industry-academia cooperation | None | 1-2 university partnerships | 6 universities + National Novel Drug Center + postdoctoral workstation |
| Ingredient R&D | Relies on purchasing | Has ingredient R&D team | Shennongjia institute, 2,000-mu base, new-ingredient filing |
| Supplier system | Domestic suppliers | Internationally renowned suppliers | Strategic global alliances with BASF, DSM, Symrise and more |
07
Four practical tips for brand owners evaluating R&D on-site01 / Tour the labs, check equipment configuration and completeness
During the visit, focus on core labs like efficacy-evaluation and active-ingredient analysis rooms — are the devices complete and actually in use? If lab equipment is covered in dust, testing capability may be only for show.
02 / Ask for the formula list, check category coverage and update frequency
Request the contract manufacturer's formula-library category list to see whether it covers the categories you need. Also learn the annual number of new formulas developed; higher update frequency signals stronger R&D vitality.
03 / Check patent certificates and special permits, gauge technical value
Ask to see original patent certificates, focusing on invention patents rather than design patents. For permits, check the count and coverage of efficacy permits like brightening and sunscreen.
04 / Ask the R&D investment ratio, gauge how much the company cares
Directly ask the R&D investment share of sales — a hard metric for whether a company truly values R&D.
When choosing a factory, what should you really look at?
A contract manufacturer's R&D strength is not about how big the plant is or how long the lines are, but whether five dimensions are solid: R&D team, patented formulas, lab equipment, industry-academia cooperation and ingredient R&D. Brand owners can match these five metrics one by one when choosing a factory, and accurately judge whether a contract manufacturer's R&D capability fits their brand needs. In the efficacy-skincare era, choosing a contract manufacturer with strong R&D is building the most core product competitiveness for your brand.